403 related articles for article (PubMed ID: 21991382)
21. Disparate bone anabolic cues activate bone formation by regulating the rapid lysosomal degradation of sclerostin protein.
Gould NR; Williams KM; Joca HC; Torre OM; Lyons JS; Leser JM; Srikanth MP; Hughes M; Khairallah RJ; Feldman RA; Ward CW; Stains JP
Elife; 2021 Mar; 10():. PubMed ID: 33779549
[TBL] [Abstract][Full Text] [Related]
22. Triple Culture of Primary Human Osteoblasts, Osteoclasts and Osteocytes as an In Vitro Bone Model.
Bernhardt A; Skottke J; von Witzleben M; Gelinsky M
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298935
[TBL] [Abstract][Full Text] [Related]
23. Osteocytes and Paget's Disease of Bone.
Tenshin H; Delgado-Calle J; Windle JJ; Roodman GD; Chirgwin JM; Kurihara N
Curr Osteoporos Rep; 2024 Apr; 22(2):266-272. PubMed ID: 38457001
[TBL] [Abstract][Full Text] [Related]
24. Sclerostin blockade inhibits bone resorption through PDGF receptor signaling in osteoblast lineage cells.
Thouverey C; Apostolides P; Brun J; Caverzasio J; Ferrari S
JCI Insight; 2024 May; 9(10):. PubMed ID: 38713511
[TBL] [Abstract][Full Text] [Related]
25. Reduced osteoprotegerin expression by osteocytes may contribute to rebound resorption after denosumab discontinuation.
Fu Q; Bustamante-Gomez NC; Reyes-Pardo H; Gubrij I; Escalona-Vargas D; Thostenson JD; Palmieri M; Goellner JJ; Nookaew I; Barnes CL; Stambough JB; Ambrogini E; O'Brien CA
JCI Insight; 2023 Sep; 8(18):. PubMed ID: 37581932
[TBL] [Abstract][Full Text] [Related]
26. Cellular response of advanced triple cultures of human osteocytes, osteoblasts and osteoclasts to high sulfated hyaluronan (sHA3).
Wirsig K; Bacova J; Richter RF; Hintze V; Bernhardt A
Mater Today Bio; 2024 Apr; 25():101006. PubMed ID: 38445011
[TBL] [Abstract][Full Text] [Related]
27. A new method to investigate how mechanical loading of osteocytes controls osteoblasts.
Vazquez M; Evans BA; Riccardi D; Evans SL; Ralphs JR; Dillingham CM; Mason DJ
Front Endocrinol (Lausanne); 2014; 5():208. PubMed ID: 25538684
[TBL] [Abstract][Full Text] [Related]
28. The Effects of Tocotrienol on Bone Peptides in a Rat Model of Osteoporosis Induced by Metabolic Syndrome: The Possible Communication between Bone Cells.
Wong SK; Chin KY; Ima-Nirwana S
Int J Environ Res Public Health; 2019 Sep; 16(18):. PubMed ID: 31505801
[TBL] [Abstract][Full Text] [Related]
29. Effects of cyclic hydraulic pressure on osteocytes.
Liu C; Zhao Y; Cheung WY; Gandhi R; Wang L; You L
Bone; 2010 May; 46(5):1449-56. PubMed ID: 20149907
[TBL] [Abstract][Full Text] [Related]
30. Co-culture of osteocytes and neurons on a unique patterned surface.
Boggs ME; Thompson WR; Farach-Carson MC; Duncan RL; Beebe TP
Biointerphases; 2011 Dec; 6(4):200-9. PubMed ID: 22239813
[TBL] [Abstract][Full Text] [Related]
31. Matrix metalloproteinase-13 is required for osteocytic perilacunar remodeling and maintains bone fracture resistance.
Tang SY; Herber RP; Ho SP; Alliston T
J Bone Miner Res; 2012 Sep; 27(9):1936-50. PubMed ID: 22549931
[TBL] [Abstract][Full Text] [Related]
32. Upregulation of inflammatory genes and downregulation of sclerostin gene expression are key elements in the early phase of fragility fracture healing.
Caetano-Lopes J; Lopes A; Rodrigues A; Fernandes D; Perpétuo IP; Monjardino T; Lucas R; Monteiro J; Konttinen YT; Canhão H; Fonseca JE
PLoS One; 2011 Feb; 6(2):e16947. PubMed ID: 21347301
[TBL] [Abstract][Full Text] [Related]
33. Connexin 43 and cell culture substrate differentially regulate OCY454 osteocytic differentiation and signaling to primary bone cells.
Hoppock GA; Buettmann EG; Denisco JA; Goldscheitter GM; Condyles SN; Juhl OJ; Friedman MA; Zhang Y; Donahue HJ
Am J Physiol Cell Physiol; 2023 Oct; 325(4):C907-C920. PubMed ID: 37602413
[TBL] [Abstract][Full Text] [Related]
34. Osteocytes directly regulate osteolysis via MYD88 signaling in bacterial bone infection.
Yoshimoto T; Kittaka M; Doan AAP; Urata R; Prideaux M; Rojas RE; Harding CV; Henry Boom W; Bonewald LF; Greenfield EM; Ueki Y
Nat Commun; 2022 Nov; 13(1):6648. PubMed ID: 36333322
[TBL] [Abstract][Full Text] [Related]
35. Competitive blocking of LRP4-sclerostin binding interface strongly promotes bone anabolic functions.
Katchkovsky S; Chatterjee B; Abramovitch-Dahan CV; Papo N; Levaot N
Cell Mol Life Sci; 2022 Jan; 79(2):113. PubMed ID: 35099616
[TBL] [Abstract][Full Text] [Related]
36. Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin.
Plotkin LI; Weinstein RS; Parfitt AM; Roberson PK; Manolagas SC; Bellido T
J Clin Invest; 1999 Nov; 104(10):1363-74. PubMed ID: 10562298
[TBL] [Abstract][Full Text] [Related]
37. Advanced oxidation protein products aggravate age‑related bone loss by increasing sclerostin expression in osteocytes via ROS‑dependent downregulation of Sirt1.
Zeng J; Xiao Q; Li X; Chen J
Int J Mol Med; 2021 Jun; 47(6):. PubMed ID: 33907818
[TBL] [Abstract][Full Text] [Related]
38. Extracellular acidification augments sclerostin and osteoprotegerin production by Ocy454 mouse osteocytes.
Ikezaki-Amada K; Miyamoto Y; Sasa K; Yamada A; Kinoshita M; Yoshimura K; Kawai R; Yano F; Shirota T; Kamijo R
Biochem Biophys Res Commun; 2022 Mar; 597():44-51. PubMed ID: 35123265
[TBL] [Abstract][Full Text] [Related]
39. Pip5k1c expression in osteocytes regulates bone remodeling in mice.
Lin S; Tao C; Yan Q; Gao H; Qin L; Zhong Y; Yao Q; Zhang P; Yang J; Zou X; Xiao G
J Orthop Translat; 2024 Mar; 45():36-47. PubMed ID: 38495744
[TBL] [Abstract][Full Text] [Related]
40. Toll-like receptor-2 induced inflammation causes local bone formation and activates canonical Wnt signaling.
Henning P; Kassem A; Westerlund A; Lundberg P; Engdahl C; Lionikaite V; Wikström P; Wu J; Li L; Lindholm C; de Souza PPC; Movérare-Skrtic S; Lerner UH
Front Immunol; 2024; 15():1383113. PubMed ID: 38646530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
